These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17992512)

  • 1. Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.
    Li Y; Cui X; Li X; Solomon SB; Danner RL; Banks SM; Fitz Y; Annane D; Natanson C; Eichacker PQ
    Intensive Care Med; 2008 Mar; 34(3):568-77. PubMed ID: 17992512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of hydrocortisone on circulating and intramyocardial inflammatory mediators in severe septic rats with myocardial injury induced by Escherichia coli].
    Wang YQ; Fan XM; Zhou T; Qi YJ; Chen H; Qian SY
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):131-5. PubMed ID: 16624031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy.
    Nasir N; Ahmed S; Razi S; Awan S; Mahmood SF
    BMC Res Notes; 2019 Sep; 12(1):611. PubMed ID: 31547853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats.
    Cui X; Zeni F; Vodovitz Y; Correa-de-Araujo R; Quezado M; Roberts A; Wahl S; Danner RL; Banks SM; Gerstenberger E; Fitz Y; Natanson C; Eichacker PQ
    Cytokine; 2003 Nov; 24(4):115-27. PubMed ID: 14572790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 inhibition impairs bacterial clearance in a therapeutic setting in murine abdominal sepsis.
    van Lieshout MH; van der Poll T; van't Veer C
    Inflamm Res; 2014 Nov; 63(11):927-33. PubMed ID: 25118783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
    Karzai W; Cui X; Mehlhorn B; Straube E; Hartung T; Gerstenberger E; Banks SM; Natanson C; Reinhart K; Eichacker PQ
    Anesthesiology; 2003 Jul; 99(1):81-9. PubMed ID: 12826846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
    Guillamet CV; Vazquez R; Noe J; Micek ST; Kollef MH
    Medicine (Baltimore); 2016 Aug; 95(35):e4708. PubMed ID: 27583907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
    Santhakumaran S; Gordon A; Prevost AT; O'Kane C; McAuley DF; Shankar-Hari M
    Crit Care; 2019 May; 23(1):156. PubMed ID: 31053084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model.
    Haley M; Parent C; Cui X; Kalil A; Fitz Y; Correa-Araujo R; Natanson C; Danner RL; Banks SM; Eichacker PQ
    J Appl Physiol (1985); 2005 Jun; 98(6):2155-62. PubMed ID: 15677732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters.
    Cheng WL; Hsueh PR; Lee CC; Li CW; Li MJ; Chang CM; Lee NY; Ko WC
    J Microbiol Immunol Infect; 2016 Apr; 49(2):208-15. PubMed ID: 25070279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia.
    Coopersmith CM; Amiot DM; Stromberg PE; Dunne WM; Davis CG; Osborne DF; Husain KD; Turnbull IR; Karl IE; Hotchkiss RS; Buchman TG
    Shock; 2003 May; 19(5):408-14. PubMed ID: 12744482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock: A Randomized Controlled Trial.
    Chang P; Liao Y; Guan J; Guo Y; Zhao M; Hu J; Zhou J; Wang H; Cen Z; Tang Y; Liu Z
    Chest; 2020 Jul; 158(1):174-182. PubMed ID: 32243943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages.
    Dufour N; Debarbieux L; Fromentin M; Ricard JD
    Crit Care Med; 2015 Jun; 43(6):e190-8. PubMed ID: 25803649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
    Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
    JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001146. PubMed ID: 19160190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Neonatal Murine
    Speer EM; Diago-Navarro E; Ozog LS; Raheel M; Levy O; Fries BC
    Front Immunol; 2020; 11():577878. PubMed ID: 33072121
    [No Abstract]   [Full Text] [Related]  

  • 19. Azithromycin in Combination with Ceftriaxone Reduces Systemic Inflammation and Provides Survival Benefit in a Murine Model of Polymicrobial Sepsis.
    Patel A; Joseph J; Periasamy H; Mokale S
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
    JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.